Target
Free fatty acid receptor 1
Ligand
BDBM300850
Substrate
n/a
Meas. Tech.
GPR40 Calcium Flux Assay
EC50
10.00±n/a nM
Citation
 Huang, HKuo, GPlayer, MRYang, SZhang, Y Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes US Patent  US10131648 Publication Date 11/20/2018 
Target
Name:
Free fatty acid receptor 1
Synonyms:
FFAR1 | FFAR1_HUMAN | G-protein Coupled Receptor 40 | GPR40
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
31473.32
Organism:
Homo sapiens (Human)
Description:
O14842
Residue:
300
Sequence:
MDLPPQLSFGLYVAAFALGFPLNVLAIRGATAHARLRLTPSLVYALNLGCSDLLLTVSLPLKAVEALASGAWPLPASLCPVFAVAHFFPLYAGGGFLAALSAGRYLGAAFPLGYQAFRRPCYSWGVCAAIWALVLCHLGLVFGLEAPGGWLDHSNTSLGINTPVNGSPVCLEAWDPASAGPARFSLSLLLFFLPLAITAFCYVGCLRALARSGLTHRRKLRAAWVAGGALLTLLLCVGPYNASNVASFLYPNLGGSWRKLGLITGAWSVVLNPLVTGYLGRGPGLKTVCAARTQGGKSQK
  
Inhibitor
Name:
BDBM300850
Synonyms:
(3S)-3-(4-((3-(5-(2- Methoxyethoxy)-3- methylpyridin-2- yl)benzo[b]thiophen-5- yl)methoxy)phenyl) hex-4-ynoic acid | US10131648, Compound 48 | US10195178, Compound 48 | US9790198, Compound 48
Type:
Small organic molecule
Emp. Form.:
C30H29NO5S
Mol. Mass.:
515.62
SMILES:
COCCOc1cnc(-c2csc3ccc(COc4ccc(cc4)[C@H](CC(O)=O)C#CC)cc23)c(C)c1 |r|
Structure:
Search PDB for entries with ligand similarity: